JNJ Today - Aug 13: Tiny Move, Big Questions
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
JNJ Today - Aug 13: Tiny Move, Big Questions
-
Letto da:
-
Di:
So, what happened? Honestly, not much. The stock just kind of floated around. Volume was right on average, so no big rush in either direction. It seems like everyone’s just waiting to see what’s next.
Now, why is that? Well, a couple of things are buzzing around. There’s some chatter about JNJ hitting that massive $100 billion revenue mark soon. That's a big deal! But then there’s also talk about some firms selling off shares, like Guardian Investment Management unloading almost 9,000 shares. That kind of stuff can make people a bit jittery. Plus, there's a comparison with AbbVie floating around, where people are weighing JNJ's safe dividend against AbbVie’s higher yield. It’s like a stock showdown, and folks are trying to figure out which is the better bet.
Oh, and JNJ is creeping up to a 52-week high. So, that’s got some folks curious—are we in for a climb, or is it just a tease?
Just a little heads up: some firms are boosting their stakes in JNJ, which might mean they see something good coming down the line.
So, yeah, that’s the scoop for today. A lot of uncertainty, but that’s stock life for ya! Remember, this is just info to keep you in the loop, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione